Home > > > > > Report Detail

Post Menopausal Osteoporosis - Pipeline Review, H1 2020

Publisher Name :
Date: 30-Apr-2020
No. of pages: 129
Inquire Before Buying

Post Menopausal Osteoporosis - Pipeline Review, H1 2020

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H1 2020, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape.

Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 4, 1, 8, 1, 8, 3 and 9 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Post Menopausal Osteoporosis (Metabolic Disorders).

- The pipeline guide reviews pipeline therapeutics for Post Menopausal Osteoporosis (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Post Menopausal Osteoporosis (Metabolic Disorders) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Post Menopausal Osteoporosis (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Post Menopausal Osteoporosis (Metabolic Disorders)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Post Menopausal Osteoporosis (Metabolic Disorders).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Post Menopausal Osteoporosis (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Post Menopausal Osteoporosis - Pipeline Review, H1 2020

Table of Contents
Introduction
Post Menopausal Osteoporosis - Overview
Post Menopausal Osteoporosis - Therapeutics Development
Post Menopausal Osteoporosis - Therapeutics Assessment
Post Menopausal Osteoporosis - Companies Involved in Therapeutics Development
Post Menopausal Osteoporosis - Drug Profiles
Post Menopausal Osteoporosis - Dormant Projects
Post Menopausal Osteoporosis - Discontinued Products
Post Menopausal Osteoporosis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Post Menopausal Osteoporosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Post Menopausal Osteoporosis - Pipeline by Ablynx NV, H1 2020
Post Menopausal Osteoporosis - Pipeline by AlphaMab Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Amgen Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by Aryogen Pharmed Co, H1 2020
Post Menopausal Osteoporosis - Pipeline by Entera Bio Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Enteris BioPharma Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by Enzene Biosciences Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Epygen Biotech Pvt Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Genor BioPharma Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Hengenix Biotech Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by Hualan Biological Engineering Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by InSight Biopharmaceuticals Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Intas Pharmaceuticals Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Ipsen SA, H1 2020
Post Menopausal Osteoporosis - Pipeline by JHL Biotech Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by Jiangsu T-mab BioPharma Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Lupin Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Luye Pharma Group Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Metabolab Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by Nano Intelligent Biomedical Engineering Corp, H1 2020
Post Menopausal Osteoporosis - Pipeline by Nanomedic Inc, H1 2020
Post Menopausal Osteoporosis - Pipeline by NeuClone Pty Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Paras Biopharmaceuticals Finland Oy, H1 2020
Post Menopausal Osteoporosis - Pipeline by Qilu Pharmaceutical Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Sandoz International GmbH, H1 2020
Post Menopausal Osteoporosis - Pipeline by Shandong Danhong Pharmaceutical Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Shanghai Biomabs Pharmaceuticals Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by Uni-Bio Science Group Ltd, H1 2020
Post Menopausal Osteoporosis - Pipeline by USV Pvt Ltd, H1 2020
Post Menopausal Osteoporosis - Dormant Projects, H1 2020
Post Menopausal Osteoporosis - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Post Menopausal Osteoporosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020
  • Global Osteoporosis Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Osteoporosis Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Osteoporosis Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Osteoporosis Drugs market. Osteoporosis Drugs are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Alendronate Sodium Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 130
    Alendronate sodium is used to prevent and treat osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios......
  • Global Alendronate Sodium Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Alendronate sodium is used to prevent and treat osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios......
  • Osteoporosis Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 93
    This study focuses on China's Osteoporosis Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. ......
  • Osteoporosis Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 67
    This study focuses on China's Osteoporosis Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions ......
  • Osteoporosis Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 205
    China's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Global Osteoporosis Drugs Market Research Report 2023, Forecast to 2028
    Published: 17-Nov-2023        Price: US 2680 Onwards        Pages: 139
    Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill. Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, ......
  • Global Risedronate Sodium Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Risedronate Sodium market: According to our latest research, the global Risedronate Sodium market looks promising in the next 5 years. As of 2022, the global Risedronate Sodium market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Risedronate Sodiu......
  • Global Raloxifene Hydrochloride Professional Survey Report 2023, Forecast to 2028
    Published: 07-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advanta......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs